Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 33 (MTND5P33) is a nuclear DNA-encoded pseudogene corresponding to the mitochondrial gene for NADH:ubiquinone oxidoreductase core subunit 5 (MT-ND5)[6]. Pseudogenes are DNA sequences similar to functional genes but are typically non-coding due to disabling mutations or premature stop codons[5]. MTND5P33 does not encode a functional protein and does not contribute directly to mitochondrial electron transport or cellular bioenergetics. Unlike its functional mitochondrial counterpart, the pseudogene has no established role in normal physiology, disease, or as a drug target. It is not currently considered clinically actionable or relevant as a therapeutic or diagnostic biomarker. While similar mitochondrial pseudogenes reflect nuclear integration events and may be informative in genetics or evolutionary studies, MTND5P33 itself is not functionally characterized and is not known to be implicated in human disease[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 33 (MTND5P33).